Recent Updates
Recently added Catalysts

BLU-782

Phase 1

Healthy Volunteers | Small molecule | Other |Blueprint Medicines Corporation|Last Updated: Nov 8, 2019

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLED
Total Trials1
Total Enrollment108
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT03858075Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy AdultsPHASE1 COMPLETED 108Feb 12, 2019Sep 11, 2019Nov 8, 20191 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Incidence and severity of adverse events (AEs) through Day 8 with a single dose of BLU-782.
Baseline to Day 8
Incidence and severity of adverse events (AEs) through Day 17 with multiple doses of BLU-782 .
Baseline to Day 17
Comparison of the concentration-time profile of BLU-782 in plasma through day 20 when taken with or without food.
Baseline to Day 20
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingQUADRUPLE
ModelSEQUENTIAL
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Single ascending doses with BLU-782EXPERIMENTAL -
Single ascending doses with placeboPLACEBO_COMPARATOR -
Multiple ascending doses with BLU-782EXPERIMENTAL -
Multiple ascending doses with placeboPLACEBO_COMPARATOR -
Food effect of BLU-782 taken with foodEXPERIMENTAL -
Food effect of BLU-782 taken without foodEXPERIMENTAL -
Interventions
NameTypeDescription
BLU-782DRUGoral capsules
PlaceboDRUGoral capsules
BLU-782 taken with foodDRUGoral capsules
Unlock Study Design Details
Eligibility Criteria
Age Range19 Years — 65 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Medically healthy * Non-smoker * Body mass index (BMI) ≥ 18 and ≤ 32 kg/m2 * No clinically significant cardiac history * No current electrocardiogram (ECG) abnormality * Female must not be of childbearing potential Exclusion Criteria: * History of or current mental or legal ...

Countries:United States
Unlock Eligibility Criteria